Effects of chronic antidepressant drug administration and electroconvulsive shock on locus coeruleus electrophysiologic activity

被引:86
作者
Grant, MM
Weiss, JM
机构
[1] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30306 USA
[2] Georgia State Univ, Dept Psychol, Atlanta, GA 30303 USA
关键词
antidepressant; locus coeruleus; electrophysiology; tricyclic; SSRI; electroconvulsive shock;
D O I
10.1016/S0006-3223(00)00936-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: The locus coeruleus (LC) is the major noradrenergic cell body group in the brain. Although previous studies have examined changes in electrophysiologic activity of LC neurons produced by antidepressant drugs, only a small number have examined changes that occur with chronic drug administration, which is the therapeutically effective regimen, and only one group of investigators has assessed effects on activated (or "burst") firing of LC neurons under such treatment conditions. The present study assessed changes produced in rats by effective antidepressant treatments-several drugs given chronically (two tricyclic antidepressants, two selective serotonin reuptake inhibitors, and a monoamine oxidase inhibitor) as well as a series of electroconvulsive shocks (ECSs)-in single-unit electrophysiologic activity of LC neurons, measuring effects on spontaneous depolarization rate and also on sensory-evoked burst firing. Methods: Drugs were administered via osmotic minipumps for either 14 or 30 days; ECSs were administered five times, with a 72-hour interval between each administration. Electrophysiologic recording of LC activity took place under halothane anesthesia on the last day of drug treatment or following a delay of I or 5 days after the final ECS. Results: A common effect of all drugs tested and ECS treatment was to decrease LC spontaneous and sensory-evoked burst firing, Conclusions: The clinical efficacy of antidepressant medication and ECS may be mediated, in part, through reduction of LC neural activity. The findings reported here are consistent with recent indications that LC neurons are hyperactive in depressed individuals and with suggestions that some behavioral changes seen in depression can arise from consequences of rapidly depolarizing LC terminals, such as release of peptides. (C) 2001 Society of Biological Psychiatry.
引用
收藏
页码:117 / 129
页数:13
相关论文
共 67 条
[1]   ALPHA-2-ADRENOCEPTOR-MEDIATED HYPERPOLARIZATION OF LOCUS COERULEUS NEURONS - INTRACELLULAR STUDIES INVIVO [J].
AGHAJANIAN, GK ;
VANDERMAELEN, CP .
SCIENCE, 1982, 215 (4538) :1394-1396
[2]  
ASTONJONES G, 1981, J NEUROSCI, V1, P887
[3]   BIOCHEMICAL EFFECTS OF ZIMELIDINE IN MAN [J].
BERTILSSON, L ;
TUCK, JR ;
SIWERS, B .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 18 (06) :483-487
[4]   DIFFERENTIAL EFFECT OF CHLORIMIPRAMINE AND NORTRIPTYLINE ON CEREBROSPINAL-FLUID METABOLITES OF SEROTONIN AND NORADRENALINE IN DEPRESSION [J].
BERTILSSON, L ;
ASBERG, M ;
THOREN, P .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 7 (05) :365-368
[5]   SEROTONINERGIC BUT NOT NORADRENERGIC NEURONS IN RAT CENTRAL-NERVOUS-SYSTEM ADAPT TO LONG-TERM TREATMENT WITH MONOAMINE-OXIDASE INHIBITORS [J].
BLIER, P ;
DEMONTIGNY, C .
NEUROSCIENCE, 1985, 16 (04) :949-955
[6]   Influence of corticotropin-releasing hormone on electrophysiological activity of locus coeruleus neurons [J].
Borsody, MK ;
Weiss, JM .
BRAIN RESEARCH, 1996, 724 (02) :149-168
[7]   EFFECTS OF AMITRIPTYLINE AND IMIPRAMINE ON BRAIN AMINE NEUROTRANSMITTER METABOLITES IN CEREBROSPINAL-FLUID [J].
BOWDEN, CL ;
KOSLOW, SH ;
HANIN, I ;
MAAS, JW ;
DAVIS, JM ;
ROBINS, E .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (03) :316-324
[8]  
BUNNEY WE, 1965, ARCH GEN PSYCHIAT, V13, P483
[9]   NORADRENERGIC NEURONS OF LOCUS COERULEUS - INHIBITION BY EPINEPHRINE AND ACTIVATION BY ALPHA-ANTAGONIST PIPEROXANE [J].
CEDARBAUM, JM ;
AGHAJANIAN, GK .
BRAIN RESEARCH, 1976, 112 (02) :413-419
[10]   EVIDENCE THAT THE ACUTE BEHAVIORAL AND ELECTROPHYSIOLOGICAL EFFECTS OF BUPROPION (WELLBUTRIN(R)) ARE MEDIATED BY A NORADRENERGIC MECHANISM [J].
COOPER, BR ;
WANG, CM ;
COX, RF ;
NORTON, R ;
SHEA, V ;
FERRIS, RM .
NEUROPSYCHOPHARMACOLOGY, 1994, 11 (02) :133-141